Sonja Fernbach

Has grant

Københavns Universitet

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Mind the RABGAP1L - a novel antiviral factor restricting virus entry?

Open Date: 2021-01-01

Close Date: 2021-10-01

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Anouk Lkharrazi

University of Zurich

SWITZERLAND

View details

Benjamin Hale

Associate Professor

University of Zurich

SWITZERLAND

View details

Silke Stertz

University of Zurich

SWITZERLAND

View details

Esther Sauras-Colón

Institut Català de la Salut

SPAIN

View details

Enos Bernasconi

Chief

SWITZERLAND

View details

Irene Abela

University of Zurich

SWITZERLAND

View details

Paraskevas Filippidis

Yale University

UNITED STATES

View details

Julia Notter

University Hospital Basel

SWITZERLAND

View details

Karoline Leuzinger

Head of Clinical Virology Department

University Hospital Basel

SWITZERLAND

View details

Christian Wandall Thorball

Lausanne University Hospital (CHUV)

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sonja Fernbach

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (9)

Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design

An atlas of protein phosphorylation dynamics during interferon signaling

Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies

Animal hepacivirus models for hepatitis C virus immune responses and pathology

SARS-CoV-2 takes the bait: Exosomes as endogenous decoys

Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2

Collaborators (10)

Anouk Lkharrazi

Benjamin Hale

Silke Stertz

Esther Sauras-Colón

Enos Bernasconi

Irene Abela

Paraskevas Filippidis

Julia Notter

Karoline Leuzinger

Christian Wandall Thorball

Make your next move.